Latest Manufacturing Processes News

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Wide Open Agriculture has received a $586,624 tax rebate for its overseas research activities in Germany, supporting the commercialisation of its proprietary lupin protein products.

Talga Group has received a significant A$13.35 million grant from the Swedish Energy Agency to advance its sustainable battery anode manufacturing project, aiming for near-industrial scale validation by mid-2026.

Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.

AML3D has secured a significant $1.7 million order for its ARCEMY X large-scale metal 3D printer from US defense supplier FasTech, marking a key milestone in its US expansion strategy.

Li-S Energy has won a $7.8 million ARENA grant to accelerate development of a lithium-sulfur battery manufacturing facility in Australia, aiming to boost production capacity from 2 MWh to 1 GWh annually.

NeuroScientific Biopharmaceuticals has initiated treatment of its fourth patient under the Special Access Scheme for StemSmart™, progressing towards a Phase 2 trial targeting severe Crohn’s disease.

Dotz Nano has successfully scaled up production of its proprietary CO₂ capture sorbents to kilogram volumes, setting the stage for commercial partnerships and cost efficiencies in the growing carbon capture market.

Metal Powder Works has secured a strategic partnership with Hardchrome Engineering, expecting USD 1-2 million in sales over the next year from innovative bronze alloy powders for laser cladding applications.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Nanoveu Limited has reported a major leap in drone endurance through its ultra-low-power AI chip technology, alongside advancing its next-generation 16 nm chip towards fabrication and expanding its U.S. sales network.